Neuland Laboratories Limited (NEULANDLAB) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Neuland Laboratories Limited stock ₹5,987, price ₹21,640, that is 72.3% below the price, quality 55 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Neuland Laboratories Limited
NEULANDLAB · NSEFar too expensive (fair value 72% below the price), but solid company and rising price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
60‑month range ₹961.69 – ₹23,995 · fair‑value band ₹4,191 – ₹7,783 · the ₹21,640 price screens above the ₹5,987 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.
Every Wednesday you see whether Neuland Laboratories is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services.
Show moreShow less
Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Stock analysis
Neuland Laboratories Limited (NEULANDLAB) currently trades at ₹21,640, while our model-based Fair Value estimate is ₹5,987, 72% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹5,987 per share, and 0 of the 16 models we run sit above the ₹21,640 price.
Bear case: the Economic Profit group reads lowest at ₹2,835, and 16 of the 16 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹4,191 (bear) to ₹7,783 (bull), the price of ₹21,640 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 55/100 (solid quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Neuland Laboratories Limited reported revenue of ₹20.2B in FY2026 versus ₹9.2B in FY2022, a compound +21.7%/yr. Reported net income was ₹3.6B in FY2026, compounding +54.5%/yr from FY2022. FY2022 was a trough year, so the rate overstates the trend.
Key figures
Market cap ₹278B (≈ $2.9B) Mid · P/E ratio 61.4 · P/S ratio 12.0 · EPS (TTM) ₹352.72 · Dividend yield 0.1% · Net margin 19.6% · Return on equity 24.8% · Return on assets (EBIT) 14.5% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 73 out of 100 (medium confidence).
What moves the price
The share trades about 10% below its 52-week high and 88% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −72%, NEULANDLAB screens richer than that median.
Fair Value models
All 16 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
NEULANDLAB screens overvalued: fair value 72% below the price. Compare with Merck KGaA →
Compare Neuland Laboratories Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Debt-to-equity by industry
- Price/FCF by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.82 | $113.53 | +35% | vs NEULANDLAB |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.02 | ¥53.04 | +10% | vs NEULANDLAB |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,868 | ₹1,983 | +6% | vs NEULANDLAB |
| Haleon plc HLN | $9.17 | $8.47 | −8% | vs NEULANDLAB |
| Merck KGaA MRK | €149.70 | €108.83 | −27% | vs NEULANDLAB |
| Galderma Group GALD | CHF 191.00 | CHF 112.30 | −41% | vs NEULANDLAB |
| Takeda Pharmaceutical Company TAK | $21.43 | $11.20 | −48% | vs NEULANDLAB |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs NEULANDLAB |
| Teva Pharmaceutical Industries Limited TEVA | $44.50 | $20.74 | −53% | vs NEULANDLAB |
| Divi's Laboratories Limited DIVISLAB | ₹11,080 | ₹1,567 | −86% | vs NEULANDLAB |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Neuland Laboratories Limited (NEULANDLAB) overvalued or undervalued?
What is the fair value of NEULANDLAB?
What is the quality score of NEULANDLAB?
What is the price target for Neuland Laboratories Limited (NEULANDLAB)?
What is the Neuland Laboratories Limited stock forecast for 2026?
What is the revenue of Neuland Laboratories Limited (NEULANDLAB)?
Does Neuland Laboratories Limited pay a dividend?
How much is the dividend of Neuland Laboratories Limited (NEULANDLAB)?
What is the intrinsic value of Neuland Laboratories Limited (NEULANDLAB)?
Is Neuland Laboratories Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of NEULANDLAB?
How much is Neuland Laboratories Limited worth?
What do the bullish and bearish scenarios say about NEULANDLAB?
What is the P/E ratio of NEULANDLAB?
How solid is the balance sheet of Neuland Laboratories Limited (NEULANDLAB)?
How far is NEULANDLAB from its 52-week high?
Which stocks are comparable to Neuland Laboratories Limited?
Is Neuland Laboratories Limited stock attractive at the current price?
How is the fair value of NEULANDLAB calculated?
Is it still worth investing in stocks now?
What is the share price of Neuland Laboratories Limited (NEULANDLAB)?
What should I pay attention to with Neuland Laboratories Limited right now?
Where does the earnings growth of Neuland Laboratories Limited (NEULANDLAB) come from?
Key figures of Neuland Laboratories Limited
How large is the market capitalisation of Neuland Laboratories Limited (NEULANDLAB)?
What is the P/S ratio of Neuland Laboratories Limited (NEULANDLAB)?
What are the earnings per share of Neuland Laboratories Limited (NEULANDLAB)?
What is the dividend yield of Neuland Laboratories Limited (NEULANDLAB)?
What is the net margin of Neuland Laboratories Limited (NEULANDLAB)?
What is the return on equity of Neuland Laboratories Limited (NEULANDLAB)?
What is the EBIT return on assets of Neuland Laboratories Limited (NEULANDLAB)?
What is the operating margin of Neuland Laboratories Limited (NEULANDLAB)?
How fast is revenue growing at Neuland Laboratories Limited (NEULANDLAB)?
How fast are earnings growing at Neuland Laboratories Limited (NEULANDLAB)?
How much free cash flow does Neuland Laboratories Limited (NEULANDLAB) generate?
How much net cash does Neuland Laboratories Limited (NEULANDLAB) hold?
Watch Neuland Laboratories Limited in the live analysis
One click puts Neuland Laboratories Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.